Author:
Stone William L.,Bharti Des,Shah Darshan S.,Hollinger Shawn
Reference99 articles.
1. Ahmed S (2016) Biomarker discovery for bronchopulmonary dysplasia using mass spectrometry based urine proteomics. http://nrs.harvard.edu/urn 3:HUL.InstRepos:33797336. p.p1
2. Ahsan H (2013) 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 74(10):1392–1399
3. Akasaki Y, Alvarez-Garcia O, Saito M, Caramés B, Iwamoto Y, Lotz MK (2014) FoxO transcription factors support oxidative stress resistance in human chondrocytes. Arthritis Rheumatol 66(12):3349–3358
4. Ambalavanan N, Cotten CM, Page GP, Carlo WA, Murray JC, Bhattacharya S et al (2015) Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr 166(3):531–537. e13
5. Balany J, Bhandari V (2015) Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia. Front Med (Lausanne) 2:90